Published in J Innate Immun on January 03, 2012
Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing. J Exp Med (2016) 1.47
Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. PLoS Pathog (2013) 1.02
Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing. PLoS Pathog (2013) 0.96
Immunogenic properties of Streptococcus agalactiae FbsA fragments. PLoS One (2013) 0.91
Platelets and infections - complex interactions with bacteria. Front Immunol (2015) 0.90
Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis. Cell Host Microbe (2015) 0.87
Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain. J Biol Chem (2013) 0.84
The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis. PLoS Pathog (2013) 0.84
Staphylococcus aureus vaccines: Deviating from the carol. J Exp Med (2016) 0.82
N-acetylglucosaminylation of serine-aspartate repeat proteins promotes Staphylococcus aureus bloodstream infection. J Biol Chem (2013) 0.82
Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data. PLoS One (2013) 0.82
Draft Genome Sequence of Bovine Mastitis Isolate Staphylococcus agnetis CBMRN 20813338. Genome Announc (2014) 0.81
Pathogenic conversion of coagulase-negative staphylococci. Microbes Infect (2016) 0.75
Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions. Adv Appl Microbiol (2016) 0.75
Evaluating the maintenance of disease-associated variation at the blood group-related gene B4galnt2 in house mice. BMC Evol Biol (2017) 0.75
Multi-mechanistic monoclonal antibodies targeting S. aureus α-toxin and clumping factor A: Activity and efficacy comparisons of a mAb combination and an engineered bispecific antibody approach. Antimicrob Agents Chemother (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Coagulase and Hemolysin Tests as Measures of the Pathogenicity of Staphylococci. J Bacteriol (1934) 19.01
Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol (1994) 5.62
Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med (2006) 5.26
THE COAGULASE TEST FOR STAPHYLOCOCCI AND ITS CORRELATION WITH THE RESISTANCE OF THE ORGANISMS TO THE BACTERICIDAL ACTION OF HUMAN BLOOD. J Clin Invest (1942) 4.66
Evidence for two forms of staphylococcal coagulase. J Gen Microbiol (1954) 4.64
Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 4.48
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 3.79
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J (2009) 2.82
The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol (1990) 2.63
Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A (2000) 2.63
Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med (2008) 2.27
The interaction of bacterial pathogens with platelets. Nat Rev Microbiol (2006) 2.26
A two-step fibrinogen--fibrin transition in blood coagulation. Nature (1978) 2.15
Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun (1985) 2.13
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
The Influence of certain Bacteria on the Coagulation of the Blood. J Med Res (1903) 2.05
Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol (2002) 2.02
Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun (2000) 1.97
Crystal structure of human fibrinogen. Biochemistry (2009) 1.97
Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature (2003) 1.92
Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood (2011) 1.87
Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog (2010) 1.75
New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost (2008) 1.73
Coagulase activity in vivo. Nature (1956) 1.70
Coagulation and innate immune responses: can we view them separately? Blood (2009) 1.61
Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.59
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog (2011) 1.57
Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun (1997) 1.57
Studies on staphylococci. II. Effect of coagulase on the virulence of coagulase negative strains. J Bacteriol (1960) 1.50
Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect Immun (1995) 1.50
Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol (2007) 1.47
Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One (2007) 1.42
Crystallization, crystal structure analysis and atomic model of the complex formed by a human Fc fragment and fragment B of protein A from Staphylococcus aureus. Hoppe Seylers Z Physiol Chem (1978) 1.40
Pathogen entrapment by transglutaminase--a conserved early innate immune mechanism. PLoS Pathog (2010) 1.39
A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A (2000) 1.36
A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology (2002) 1.31
Clumping of Staphylococcus aureus in the peritoneal cavity of mice. J Bacteriol (1966) 1.30
Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci U S A (2009) 1.28
Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol (2011) 1.27
The central role of thrombin in hemostasis. J Thromb Haemost (2007) 1.26
Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J Med Microbiol (1994) 1.23
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med (2005) 1.23
Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood (2010) 1.23
The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett (2004) 1.22
Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. J Biochem (1985) 1.20
Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem (1983) 1.20
Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun (2001) 1.18
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood (2011) 1.15
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J (2006) 1.13
The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem (1999) 1.12
Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J Bacteriol (2005) 1.11
Localization of bacteriophage receptor, clumping factor, and protein A on the cell surface of Staphylococcus aureus. J Bacteriol (1980) 1.10
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood (2000) 1.08
Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol Immunol (1989) 1.04
Molecular cloning and expression of the coagulase gene of Staphylococcus aureus 8325-4. J Gen Microbiol (1988) 1.03
Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) (2009) 1.00
Histopathology and pathogenesis of mouse mastitis induced with Staphylococcus aureus mutants. J Comp Pathol (1984) 0.98
Staphylocoagulase-binding region in human prothrombin. J Biochem (1985) 0.97
Study of thrombin-coagulase. Thromb Diath Haemorrh (1967) 0.94
Sol Sherry Lecture in Thrombosis : research on clot stabilization provides clues for improving thrombolytic therapies. Arterioscler Thromb Vasc Biol (2000) 0.92
ABSCESS-FORMING FACTOR(S) PRODUCED BY STAPHYLOCOCCUS AUREUS. I. COLLODION BAG IMPLANTATION TECHNIQUE. J Bacteriol (1963) 0.91
Plasma and cellular contributions to fibrin network formation, structure and stability. Haemophilia (2010) 0.91
ABSCESS-FORMING FACTOR(S) PRODUCED BY STAPHYLOCOCCUS AUREUS. II. ABSCESS FORMATION AND IMMUNITY BY A STAPHYLOCOCCUS AND ITS MUTANTS. J Bacteriol (1963) 0.89
Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation (2004) 0.89
Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis (2010) 0.88
Staphylokinase; an activator of plasma protease. Nature (1948) 0.87
The role of coagulase in the defence of Staphylococcus aureus against phagocytosis. Br J Exp Pathol (1969) 0.85
Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin. J Biochem (1985) 0.85
Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action. Thromb Diath Haemorrh (1967) 0.84
Coagulation factor XIII variants with altered thrombin activation rates. Biol Chem (2009) 0.80
Dabigatran inhibits Staphylococcus aureus coagulase activity. J Clin Microbiol (2010) 0.80
Disulfide bond reduction in fibrinogen: calcium protection and effect on clottability. Biochemistry (1990) 0.79
Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin. J Biol Chem (1996) 0.78
Action of staphylothrombin on bovine fibrinogen. Thromb Res (1975) 0.77
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid (2005) 6.11
Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med (2007) 5.95
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev (2006) 4.88
Passage of heme-iron across the envelope of Staphylococcus aureus. Science (2003) 4.83
Iron-source preference of Staphylococcus aureus infections. Science (2004) 4.33
Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis (2010) 4.19
Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis (2008) 4.16
Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol (2007) 4.07
Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med (2008) 4.01
Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci U S A (2004) 3.89
Assembly of pili on the surface of Corynebacterium diphtheriae. Mol Microbiol (2003) 3.79
Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun (2006) 3.41
Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science (2013) 3.32
Plague bacteria target immune cells during infection. Science (2005) 3.32
An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc Natl Acad Sci U S A (2002) 3.23
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J (2009) 2.82
Sortases and pilin elements involved in pilus assembly of Corynebacterium diphtheriae. Mol Microbiol (2004) 2.80
Assembly of pili in Gram-positive bacteria. Trends Microbiol (2004) 2.76
Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A (2006) 2.71
Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol (2006) 2.54
Protein sorting to the cell wall envelope of Gram-positive bacteria. Biochim Biophys Acta (2004) 2.42
EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc Natl Acad Sci U S A (2005) 2.42
IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem (2003) 2.39
Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect (2004) 2.37
The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe (2007) 2.26
Prophages of Staphylococcus aureus Newman and their contribution to virulence. Mol Microbiol (2006) 2.20
Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis (2011) 2.19
Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol (2005) 2.07
Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc Natl Acad Sci U S A (2007) 2.06
Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring. J Biol Chem (2002) 1.97
Substrate recognition by the Yersinia type III protein secretion machinery. Mol Microbiol (2003) 1.93
hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology (2004) 1.91
Inactivation of the srtA gene in Listeria monocytogenes inhibits anchoring of surface proteins and affects virulence. Mol Microbiol (2002) 1.89
Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med (2009) 1.85
An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus. Nat Chem Biol (2006) 1.83
Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch Pathol Lab Med (2011) 1.83
Architects at the bacterial surface - sortases and the assembly of pili with isopeptide bonds. Nat Rev Microbiol (2011) 1.79
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med (2010) 1.77
The structure of sortase B, a cysteine transpeptidase that tethers surface protein to the Staphylococcus aureus cell wall. Structure (2004) 1.76
Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog (2010) 1.75
Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol (2006) 1.72
Assembly of pili on the surface of Bacillus cereus vegetative cells. Mol Microbiol (2007) 1.67
Sortase as a target of anti-infective therapy. Pharmacol Rev (2008) 1.64
Iron acquisition and transport in Staphylococcus aureus. Biometals (2006) 1.61
Protein secretion and surface display in Gram-positive bacteria. Philos Trans R Soc Lond B Biol Sci (2012) 1.61
BslA, a pXO1-encoded adhesin of Bacillus anthracis. Mol Microbiol (2008) 1.60
Crystal structures of Staphylococcus aureus sortase A and its substrate complex. J Biol Chem (2004) 1.60
Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis. J Bacteriol (2006) 1.59
Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe (2008) 1.59
Staphylococcus aureus IsdG and IsdI, heme-degrading enzymes with structural similarity to monooxygenases. J Biol Chem (2004) 1.58
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog (2011) 1.57
LcrV plague vaccine with altered immunomodulatory properties. Infect Immun (2005) 1.57
IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine (2010) 1.57
Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol (2011) 1.54
A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol (2011) 1.53
Amide bonds assemble pili on the surface of bacilli. Proc Natl Acad Sci U S A (2008) 1.53
Bacillus anthracis IsdG, a heme-degrading monooxygenase. J Bacteriol (2006) 1.51
Targeting proteins to the cell wall of sporulating Bacillus anthracis. Mol Microbiol (2006) 1.49
Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J Bacteriol (2007) 1.48
Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin. PLoS Pathog (2008) 1.47
Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope. J Bacteriol (2005) 1.46
YopD and LcrH regulate expression of Yersinia enterocolitica YopQ by a posttranscriptional mechanism and bind to yopQ RNA. J Bacteriol (2002) 1.44
On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis. J Infect Dis (2002) 1.39
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med (2011) 1.38
Type iii protein secretion in yersinia species. Annu Rev Cell Dev Biol (2002) 1.38
Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus. EMBO J (2008) 1.35
Anchor structure of staphylococcal surface proteins. V. Anchor structure of the sortase B substrate IsdC. J Biol Chem (2005) 1.34
Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Cysteine 184 and histidine 120 of sortase form a thiolate-imidazolium ion pair for catalysis. J Biol Chem (2001) 1.33
Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun (2008) 1.32
Intramolecular amide bonds stabilize pili on the surface of bacilli. Proc Natl Acad Sci U S A (2009) 1.31
EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Mol Microbiol (2008) 1.30
Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS. Proc Natl Acad Sci U S A (2009) 1.30
Characterization of the Yersinia enterocolitica type III secretion ATPase YscN and its regulator, YscL. J Bacteriol (2006) 1.29
Distribution of protein A on the surface of Staphylococcus aureus. J Bacteriol (2007) 1.28
Effect of srtA and srtB gene expression on the virulence of Staphylococcus aureus in animal models of infection. J Antimicrob Chemother (2004) 1.28
The YSIRK-G/S motif of staphylococcal protein A and its role in efficiency of signal peptide processing. J Bacteriol (2003) 1.27
The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect (2003) 1.26
Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio (2013) 1.26
Sortase D forms the covalent bond that links BcpB to the tip of Bacillus cereus pili. J Biol Chem (2009) 1.25
Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. Proc Natl Acad Sci U S A (2006) 1.23
Bacillus anthracis surface-layer proteins assemble by binding to the secondary cell wall polysaccharide in a manner that requires csaB and tagO. J Mol Biol (2010) 1.21
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun (2006) 1.21
Racemic crystallography of synthetic protein enantiomers used to determine the X-ray structure of plectasin by direct methods. Protein Sci (2009) 1.20
Generating a collection of insertion mutations in the Staphylococcus aureus genome using bursa aurealis. Methods Mol Biol (2008) 1.19
EsaD, a secretion factor for the Ess pathway in Staphylococcus aureus. J Bacteriol (2011) 1.18
Structures of sortase B from Staphylococcus aureus and Bacillus anthracis reveal catalytic amino acid triad in the active site. Structure (2004) 1.18
Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect Immun (2008) 1.18